Learn / VTRS
NASDAQ: VTRS
Viatris (VTRS) stock, explained like you're 5
Viatris trades on the Nasdaq under the ticker VTRS. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 20.3 billion dollars.
- Ticker
- VTRS
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Large cap, about 20.3 billion dollars
Is Viatris a small, medium or large cap company?
Yes. Viatris is a large cap stock. Its market cap, which is the total value of all its shares, is about 20.3 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Viatris makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves VTRS stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Presbyopia Approval Might Change The Case For Investing In Viatris Stock (VTRS) (Simply Wall Street)
- Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non Opioid Pain Therapies (Viatris Newsroom)
- Is Viatris Stock Outperforming the S&P 500? (Yahoo Finance)
- Viatris Inc. stock rises Thursday, outperforms market (MarketWatch)
- The FDA approves Viatris eye drops for adults who struggle to focus up close (Stock Titan)
Follow VTRS in your daily brief
Each trading day at 5 PM ET we post what happened to Viatris and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow VTRS
Questions about Viatris stock
What does Viatris do?
Viatris trades on the Nasdaq under the ticker VTRS. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 20.3 billion dollars.
What is the ticker symbol for Viatris?
Viatris trades under the ticker VTRS on the Nasdaq.
What is Viatris's market cap?
Viatris is a large cap stock with a market cap of about 20.3 billion dollars.
How does Viatris make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves VTRS stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow VTRS stock every day?
Add VTRS to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.